Tag: clinicaltrials

AstraZeneca to seek accelerated approval of Ultomirisin in immunoglobulin A nephropathy on phase 3 data

Tenvie doses first subject in phase 1 TNV108 trial for peripheral neuropathies

Preliminary AMT-191 phase 1/2a data shows sustained increases in α-Gal A enzyme activity in patients with Fabry Disease

Positive phase 3 topline results for oral infigratinib

Preclinical data published in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5)

Positive longer-term phase 1 data of Nexiguran Ziclumeran (nex-z) in patients with Transthyretin Amyloidosis with cardiomyopathy

Breakthrough method for early-phase evaluation of topical drugs using quantitative gene expression

Amgen advances toward lupus redemption while gastric cancer candidate struggles

Phase 3 antifungal trial cancelled over low response, higher mortality rate

Hutchmed to file for approval of sovleplenib in China in the first half of 2026